These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10889140)

  • 1. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol.
    Wijffels MC; Dorland R; Mast F; Allessie MA
    Circulation; 2000 Jul; 102(2):260-7. PubMed ID: 10889140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
    Wijffels MC; Dorland R; Allessie MA
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):178-93. PubMed ID: 10090222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
    Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractionation of electrograms and linking of activation during pharmacologic cardioversion of persistent atrial fibrillation in the goat.
    Shan Z; Van Der Voort PH; Blaauw Y; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2004 May; 15(5):572-80. PubMed ID: 15149428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation.
    van Brakel TJ; Hermans JJ; Accord RE; Schotten U; Smits JF; Allessie MA; Maessen JG
    J Cardiovasc Electrophysiol; 2009 Feb; 20(2):207-15. PubMed ID: 19175851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of pharmacologic cardioversion of atrial fibrillation by Class I drugs.
    Allessie MA; Wijffels MC; Dorland R
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S69-77. PubMed ID: 9727679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs.
    Duytschaever M; Blaauw Y; Allessie M
    Cardiovasc Res; 2005 Jul; 67(1):69-76. PubMed ID: 15949471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of progressive widening of the temporal excitable gap for perpetuation of atrial fibrillation in the goat.
    Shan Z; Yan J; Zhou J; Shi X; Guo J; Yuan H; Allessie MA; Wang Y
    Circ J; 2010 Apr; 74(4):655-63. PubMed ID: 20190426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in the spatial dispersion at the termination of atrial fibrillation by intravenous cibenzoline.
    Kakugawa H; Shimizu A; Yamagata T; Esato M; Ueyama T; Yoshiga Y; Kanemoto M; Matsuzaki M
    Circ J; 2003 Oct; 67(10):810-5. PubMed ID: 14578610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.
    Blaauw Y; Schotten U; van Hunnik A; Neuberger HR; Allessie MA
    Cardiovasc Res; 2007 Jul; 75(1):89-98. PubMed ID: 17466958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profibrillatory effects of verapamil but not of digoxin in the goat model of atrial fibrillation.
    Duytschaever MF; Garratt CJ; Allessie MA
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1375-85. PubMed ID: 11196562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
    Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
    Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial correlation analysis of the pharmacological conversion of sustained atrial fibrillation in conscious goats by cibenzoline.
    Hoekstra BP; Diks CG; Allessie MA; DeGoede J
    Arch Physiol Biochem; 2000 Oct; 108(4):332-48. PubMed ID: 11094385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for determining the refractory period and excitable gap during persistent atrial fibrillation in the goat.
    Duytschaever M; Mast F; Killian M; Blaauw Y; Wijffels M; Allessie M
    Circulation; 2001 Aug; 104(8):957-62. PubMed ID: 11514386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.
    Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of quinidine, flecainide, and cibenzoline on anisotropic conduction in the isolated porcine heart.
    Lacroix D; Delfaut P; Adamantidis M; Cardinal R; Klug D; Kacet S; Dupuis B
    J Cardiovasc Electrophysiol; 1998 Jan; 9(1):55-69. PubMed ID: 9475578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.
    Blaauw Y; Gögelein H; Tieleman RG; van Hunnik A; Schotten U; Allessie MA
    Circulation; 2004 Sep; 110(13):1717-24. PubMed ID: 15364815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.